A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

ActivePure Medical Joins Forces with Lighthouse Environmental Infection Prevention

ActivePure Medical LLC, the healthcare division of ActivePure Technologies LLC, announced today that Lighthouse Environmental Infection Prevention, the worldwide leader in environmental infection prevention and control, will represent the company as its acute care customer acquisition team in the United States.

Lighthouse is led by John LaRochelle, a former executive at Sodexo where he managed their global cleaning and disinfecting portfolio. Lighthouse’s team of infection prevention advisors has decades of experience finding, developing and implementing innovative solutions to reduce infection rates in healthcare systems. Lighthouse excels at developing custom solutions that improve the environment of care and they currently service more than 500 hospitals nationwide.

Lighthouse has partnered with ActivePure Medical, formerly Aerus Medical, to add continuous disinfection technology to their portfolio to address the contamination that occurs in between the routine cleaning and disinfection. ActivePure offers a range of continuous, full-facility surface and air disinfection products specifically designed for healthcare settings.

“We are excited to partner with ActivePure Medical.  Their best-in-class ActivePure Technology is an important addition to our portfolio of technologies, services, environmental testing and consulting services to stop the transmission of pathogens in healthcare facilities and reduce HAIs.  ActivePure’s FDA cleared class II medical devices, extensive clinical testing showing effectiveness, range of products and expertise assures we can create a solution for most healthcare facilities,” states Doug Manchester, Managing Partner of Lighthouse Environmental Infection Prevention.

ActivePure Medical and Lighthouse will position ozone-free, CARB certified ActivePure Guardian products made in EPA-registered establishment number 87327-VA-1 under ActivePure Manufacturing, LLC, in the hospital market. The industry-leading ActivePure Medical Guardian, an FDA cleared Class II Medical Device which received 510k status in 2020, will be among the products available.

“This opportunity provides Lighthouse improved access to our gold-standard continuous surface and air disinfection products and will enhance their comprehensive environmental infection prevention programs. ActivePure is the only brand that offers automated, proactive, and full-facility continuous surface and air disinfection that minimize pathogens and contaminants in the air and on surfaces in real-time and in areas occupied by patients and staff,” said Dan Marsh, president of ActivePure Medical. “Acute care facilities are an important channel for us, and we are very passionate about helping them in their efforts to achieve zero healthcare-associated infections (HAIs).”

All ActivePure Guardian products are designed to be effective against the most resistant pathogens found in the healthcare environment, such as MRSA, VRE, and c. Difficile spores. The ActivePure Technology has been independently tested against a broad spectrum of clinically relevant surface and airborne pathogens, including H1N1, SARS-CoV-2, Aspergillus Niger, and more. Testing can be found on file at ActivePureMedical.com. ActivePure Medical Guardian is currently undergoing a two-year, double-blind study at the Cleveland Clinic to measure effectiveness against Surgical Site Infections (SSIs). ActivePure has other real-environment case studies, including in healthcare spaces showing significant reductions in bacteria, viruses, and incidences of MRSA.

ActivePure Medical products are safe to use in spaces occupied by people, making the suite of continuous surface and air disinfection products an ideal solution for facility-wide adoption in the healthcare space. These safe and highly effective products come in both heating, ventilation and air conditioning (HVAC) induction variations and plug-and-play, installation-free portable units. The types of ActivePure Guardian units configured for medical facilities depend largely on the facility’s HVAC plans, layout, and independent needs or risks; most facilities use a combination of portable and induct units. To ensure that every healthcare facility has the ideal solution, ActivePure Medical’s team of experts will consult and review each facility’s specific infection prevention needs and propose a customized solution for the space.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy